Viggo Van Tendeloo

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

Viggo Van Tendeloo, Peter Ponsaerts, Filip Lardon et al. · Blood · 2001 · 458 citations · Full text

Pharmacy, Biomedical Engineering, Immunology +17

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo Van Tendeloo, Ann Van de Velde, Ann Van Driessche et al. · Proceedings of the National Academy of Sciences · 2010 · 372 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille, Ann L. Van de Velde, Evelien Smits et al. · Blood · 2017 · 233 citations · Full text

Medicine, Immunology, Oncology +15

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein

Ken Op de Beeck, Guy Van Camp, Sofie Thys et al. · European Journal of Human Genetics · 2011 · 133 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice

Irene Bergwerf, Nathalie De Vocht, Bart Tambuyzer et al. · BMC Biotechnology · 2009 · 132 citations · Full text

Life Sciences, Biotechnology, Cell Biology +15